GoldBamboo.com - Knowledge is strong medicine
  

Lactic Acid in the Rectum and Life-Threatening Infection. - Article


  Not Signed In - Sign In / Register






Gamma-Linolenic Acid (GLA)


Clinical Trial: Lactic Acid in the Rectum and Life-Threatening Infection.

This study is not yet open for patient recruitment.
Verified by Copenhagen University Hospital at Herlev September 2005

Sponsored by: Copenhagen University Hospital at Herlev
Information provided by: Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier: NCT00197938

Purpose

Life-threatening infection impairs bloodflow to the gut, thereby causing less delivery of oxygen. This leads to increased formation of lactic acid.

We hypothesize, that the more serious the condition, the higher the concentration of lactic acid will be, thus relating to the risk of multiple organ failure or death.

Condition Intervention
Septic Shock
 Procedure: Measurement of rectal lactic acid.

MedlinePlus related topics:  Sepsis

Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Prospective Study

Official Title: Does the Concentration of L-Lactate in the Rectum Correlate with Mortality and Morbidity in Patients with Septic Shock?

Further Study Details: 

Expected Total Enrollment:  150

Study start: November 2005;  Expected completion: December 2006
Last follow-up: December 2006;  Data entry closure: December 2006

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Fluid resuscitated septic shock < 24 h.

Exclusion Criteria:

  • Septic shock > 24 h.
  • Pathology in the rectum.
  • Bleeding per rectum.
  • Limitation of therapy
  • Where informed consent from relatives cannot be obtained.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00197938

Michael Ibsen, MD      +45 44 88 35 95    micibs@dadlnet.dk
Anders Perner, MD, PhD      +45 44 88 38 39    ap@dadlnet.dk

Denmark
      Dept. of Intensive Care, Herlev University Hospital, Herlev,  DK-2730,  Denmark
Michael Ibsen, MD  +45 44 88 35 95    micibs@dadlnet.dk 

      Dept. of Intensive Care, Glostrup University Hospital, Glostrup,  DK-2600,  Denmark
Thomas Mohr, MD, PhD  +45 43 23 23 00 

      Dept. of Intensive Care, Gentofte University Hospital, Hellerup,  DK-2900,  Denmark
Lone Møller Poulsen, MD  +45 39 77 37 73 

      Dept. of Intensive Care 4131, Rigshospitalet, Copenhagen,  DK-2100,  Denmark
Jørgen Wiis, MD  +45 35 45 35 45 

Finland
      Dept. of Intensive Care, Tampere University Hospital, Tampere,  33521,  Finland
Jyrki Tenhunen, MD, PhD  +358 3 311 611 

Study chairs or principal investigators

Anders Perner, MD, PhD,  Study Chair,  Dept. of Anaesthesia and Intensive Care, Herlev University Hospital, DK-2730 Herlev   

More Information

Study ID Numbers:  KA 05091m
Last Updated:  September 19, 2005
Record first received:  September 14, 2005
ClinicalTrials.gov Identifier:  NCT00197938
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics
ClinicalTrials.gov processed this record on 2005-09-20


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Gamma-Linolenic Acid (GLA).

October 13, 2008



Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.